HMG-CoA reductase activity in human liver microsomes: comparative inhibition by statins
- 31 May 2000
- journal article
- research article
- Published by Elsevier in Experimental and Toxicologic Pathology
- Vol. 52 (2) , 145-148
- https://doi.org/10.1016/s0940-2993(00)80107-4
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- 93 Cerivastatin: High enzyme affinity and active metabolites contribute to its high pharmacological activityAtherosclerosis, 1997
- Cerivastatin, a New Potent Synthetic HMG Co-A Reductase Inhibitor: Effect of 0.2 mg Daily in Subjects With Primary HypercholesterolemiaJournal of Cardiovascular Pharmacology and Therapeutics, 1997
- Inhibitors of cholesterol biosynthesis. 3. Tetrahydro-4-hydroxy-6-[2-(1H-pyrrol-1-yl)ethyl]-2H-pyran 2-one inhibitors of HMG-CoA reductase. 2. Effects of introducing substituents at positions three and four of the pyrrole nucleusJournal of Medicinal Chemistry, 1991
- Hep-G2 cells and primary rat hepatocytes differ in their response to inhibitors of HMG-CoA reductaseBiochemical and Biophysical Research Communications, 1990
- Inhibitors of cholesterol biosynthesis. 1. trans-6-(2-Pyrrol-1-ylethyl)-4-hydroxypyran-2-ones, a novel series of HMG-CoA reductase inhibitors. 1. Effects of structural modifications at the 2- and 5-positions of the pyrrole nucleusJournal of Medicinal Chemistry, 1990
- HMGCoA reductase and cholesterol 7α-hydroxylase in human liverLife Sciences, 1984
- Cytochrome P-450 Monooxygenase Activities in Human and Rat Liver MicrosomesEuropean Journal of Biochemistry, 1981
- Feedback Regulation of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase in Livers of Mice Treated with Mevinolin, a Competitive Inhibitor of the ReductaseJournal of Clinical Investigation, 1980
- Hepatic HMGCoA reductase in human cholelithiasis: effects of chenodeoxycholic and ursodeoxycholic acids*European Journal of Clinical Investigation, 1980
- Competitive inhibition of 3‐hydroxy‐3‐methylglutaryl coenzyme a reductase by ML‐236A and ML‐236B fungal metabolites, having hypocholesterolemic activityFEBS Letters, 1976